Compare Stocks: AVTR, BIO, and BRKR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTR Avantor	$14.55 +0.9%	$11.82	$7.26 ▼ $15.93	$9.84B	0.89	10.43 million shs	4.77 million shs
BIO Bio-Rad Laboratories	$391.29 +0.2%	$319.88	$236.73 ▼ $393.10	$10.46B	1.06	323,851 shs	221,653 shs
BRKR Bruker	$57.06 +0.4%	$58.69	$28.53 ▼ $65.30	$8.69B	1.28	2.38 million shs	2.53 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTR Avantor	+1.15%	+8.05%	+25.93%	+72.00%	+9.18%
BIO Bio-Rad Laboratories	+2.33%	+10.66%	+24.32%	+27.71%	+31.52%
BRKR Bruker	-0.23%	-0.02%	-5.96%	+16.93%	+64.26%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTR Avantor	$14.55 +0.9%	$11.82	$7.26 ▼ $15.93	$9.84B	0.89	10.43 million shs	4.77 million shs
BIO Bio-Rad Laboratories	$391.29 +0.2%	$319.88	$236.73 ▼ $393.10	$10.46B	1.06	323,851 shs	221,653 shs
BRKR Bruker	$57.06 +0.4%	$58.69	$28.53 ▼ $65.30	$8.69B	1.28	2.38 million shs	2.53 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTR Avantor	+1.15%	+8.05%	+25.93%	+72.00%	+9.18%
BIO Bio-Rad Laboratories	+2.33%	+10.66%	+24.32%	+27.71%	+31.52%
BRKR Bruker	-0.23%	-0.02%	-5.96%	+16.93%	+64.26%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVTR Avantor	2.06	Hold	$12.00	-17.53% Downside
BIO Bio-Rad Laboratories	2.20	Hold	$343.33	-12.26% Downside
BRKR Bruker	2.57	Moderate Buy	$56.64	-0.73% Downside

Current Analyst Ratings Breakdown

Latest AVTR, BIO, and BRKR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	BIO Bio-Rad Laboratories	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Hold (C-)
8/11/2026	BIO Bio-Rad Laboratories	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/5/2026	BRKR Bruker	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$50.00
8/5/2026	BIO Bio-Rad Laboratories	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral ➝ Hold	$300.00 ➝ $330.00
8/5/2026	BIO Bio-Rad Laboratories	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$320.00 ➝ $370.00
8/5/2026	BIO Bio-Rad Laboratories	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$310.00 ➝ $330.00
8/5/2026	BRKR Bruker	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral ➝ Hold	$60.00 ➝ $53.00
8/4/2026	BRKR Bruker	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/3/2026	BIO Bio-Rad Laboratories	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
7/30/2026	AVTR Avantor	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sector Perform	$9.00 ➝ $14.00
7/30/2026	AVTR Avantor	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$13.00

(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVTR Avantor	$6.55B	1.50	$1.54 per share	9.42	$8.32 per share	1.75
BIO Bio-Rad Laboratories	$2.58B	4.05	$10.27 per share	38.09	$268.30 per share	1.46
BRKR Bruker	$3.50B	2.48	$3.38 per share	16.88	$15.75 per share	3.62

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVTR Avantor	-$530.20M	-$0.84	N/A	16.72	10.76	-8.81%	9.92%	4.75%	11/4/2026 (Estimated)
BIO Bio-Rad Laboratories	$759.90M	$8.25	47.43	43.33	N/A	8.59%	3.54%	2.48%	10/29/2026 (Estimated)
BRKR Bruker	-$8.60M	-$0.70	N/A	23.48	1.74	-2.35%	12.47%	4.91%	11/2/2026 (Estimated)

Latest AVTR, BIO, and BRKR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2026	Q2 2026	BIO Bio-Rad Laboratories	$1.75	$2.62	+$0.87	$13.85	$623.99 million	$651.00 million
8/4/2026	Q2 2026	BRKR Bruker	$0.3849	$0.49	+$0.1051	-$0.41	$853.57 million	$838.50 million
7/29/2026	Q2 2026	AVTR Avantor	$0.1915	$0.21	+$0.0185	$0.06	$1.61 billion	$1.69 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVTR Avantor	N/A	N/A	N/A	N/A	N/A
BIO Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A
BRKR Bruker	$0.20	0.35%	+4.56%	N/A	N/A

Latest AVTR, BIO, and BRKR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/14/2026	BRKR Bruker	quarterly	$0.05	0.35%	9/21/2026	9/21/2026	10/7/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVTR Avantor	0.65	1.78	1.18
BIO Bio-Rad Laboratories	0.11	3.14	2.33
BRKR Bruker	0.76	1.85	0.92

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVTR Avantor	95.08%
BIO Bio-Rad Laboratories	65.24%
BRKR Bruker	79.52%

Insider Ownership

Company	Insider Ownership
AVTR Avantor	0.28%
BIO Bio-Rad Laboratories	30.34%
BRKR Bruker	27.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVTR Avantor	13,500	676.36 million	674.47 million	Optionable
BIO Bio-Rad Laboratories	7,450	26.74 million	18.63 million	Optionable
BRKR Bruker	11,085	152.36 million	110.92 million	Optionable

AVTR, BIO, and BRKR Headlines

Recent News About These Companies

PDT Partners LLC Acquires Shares of 68,292 Bruker Corporation $BRKR

August 26 at 5:52 AM | marketbeat.com

Palisade Capital Management LP Acquires Shares of 210,024 Bruker Corporation $BRKR

August 26 at 5:52 AM | marketbeat.com

Expect Equity LLC Purchases New Position in Bruker Corporation $BRKR

August 26 at 4:23 AM | marketbeat.com

134,270 Shares in Bruker Corporation $BRKR Bought by Castleark Management LLC

August 26 at 4:16 AM | marketbeat.com

49,900 Shares in Bruker Corporation $BRKR Bought by Pinnbrook Capital Management LP

August 23 at 6:31 AM | marketbeat.com

27,061 Shares in Bruker Corporation $BRKR Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

August 22, 2026 | marketbeat.com

Ceredex Value Advisors LLC Acquires Shares of 213,450 Bruker Corporation $BRKR

August 21, 2026 | marketbeat.com

Advisors Capital Management LLC Purchases Shares of 81,937 Bruker Corporation $BRKR

August 21, 2026 | marketbeat.com

2,823,178 Shares in Bruker Corporation $BRKR Acquired by Edmond DE Rothschild Holding S.A.

August 20, 2026 | marketbeat.com

Bruker Corporation (NASDAQ:BRKR) Given Consensus Recommendation of "Moderate Buy" by Brokerages

August 20, 2026 | marketbeat.com

Pallas Capital Advisors LLC Purchases New Stake in Bruker Corporation $BRKR

August 18, 2026 | marketbeat.com

Old West Investment Management LLC Acquires Shares of 667,103 Bruker Corporation $BRKR

August 17, 2026 | marketbeat.com

Handelsbanken Fonder AB Acquires 18,165 Shares of Bruker Corporation $BRKR

August 16, 2026 | marketbeat.com

44,895 Shares in Bruker Corporation $BRKR Purchased by Walleye Trading LLC

August 15, 2026 | marketbeat.com

Bruker Corporation $BRKR Shares Sold by Bank of America Corp DE

August 15, 2026 | marketbeat.com

Bruker Board Declares Quarterly Cash Dividend for Shareholders

August 14, 2026 | tipranks.com

Bruker Corporation: Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

August 12, 2026 | finanznachrichten.de

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

August 12, 2026 | rutlandherald.comR

The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call

August 11, 2026 | theglobeandmail.com

Bruker Corporation: Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

August 10, 2026 | finanznachrichten.de

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

August 10, 2026 | rutlandherald.comR

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AVTR, BIO, and BRKR Company Descriptions

Avantor NYSE:AVTR

$14.55 +0.13 (+0.90%)

As of 03:58 PM Eastern

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Bio-Rad Laboratories NYSE:BIO

$391.29 +0.95 (+0.24%)

As of 03:58 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bruker NASDAQ:BRKR

$57.06 +0.21 (+0.37%)

As of 04:00 PM Eastern

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AVTR, BIO, and BRKR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AVTR, BIO, and BRKR Earnings

Compare Dividends

Latest AVTR, BIO, and BRKR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AVTR, BIO, and BRKR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AVTR, BIO, and BRKR Company Descriptions

Avantor NYSE:AVTR

Bio-Rad Laboratories NYSE:BIO

Bruker NASDAQ:BRKR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AVTR, BIO, and BRKR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AVTR, BIO, and BRKR Earnings

Compare Dividends

Latest AVTR, BIO, and BRKR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AVTR, BIO, and BRKR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AVTR, BIO, and BRKR Company Descriptions

Avantor NYSE:AVTR

Bio-Rad Laboratories NYSE:BIO

Bruker NASDAQ:BRKR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools